Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank93
3Y CAGR+8.5%
5Y CAGR+14.9%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+8.5%/yr
vs +8.0%/yr prior
5Y CAGR
+14.9%/yr
Recent deceleration
Acceleration
+0.5pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $2.70B | -8.6% |
| 2024 | $2.95B | +16.3% |
| 2023 | $2.54B | +20.0% |
| 2022 | $2.12B | +15.9% |
| 2021 | $1.82B | +35.6% |
| 2020 | $1.35B | +0.3% |
| 2019 | $1.34B | -13.8% |
| 2018 | $1.56B | +17.9% |
| 2017 | $1.32B | +12.1% |
| 2016 | $1.18B | - |